Chuikyo OKs Optimal Use Guidelines for Opdivo and Keytruda, Due Out Feb. 14

February 9, 2017
Bill Payer Rep Yoshimori (left) at Chuikyo General Meeting on Feb. 8 The Central Social Insurance Medical Council, the health ministry’s key reimbursement policy panel better known as Chuikyo, approved on February 8 four “optimal use promotion guidelines” for the...read more